Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Frankfurt - Delayed Quote EUR

Bioextrax AB (publ) (85X0.F)

Compare
0.2110
+0.0120
+(6.03%)
As of 3:29:02 PM GMT+2. Market Open.
Loading Chart for 85X0.F
  • Previous Close 0.1990
  • Open 0.2170
  • Bid 0.2070 x --
  • Ask 0.2160 x --
  • Day's Range 0.2070 - 0.2170
  • 52 Week Range 0.1586 - 0.3505
  • Volume 0
  • Avg. Volume 0
  • Market Cap (intraday) 9.986M
  • Beta (5Y Monthly) 2.52
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0500
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Bioextrax AB (publ) develops and commercializes a bio-based extraction platform technology. It harvests bioplastics (PHA) granules, organic hydrolyzed protein, keratin fibers, bio-oils, protein-rich by products, and amino acids from bacteria. The company was incorporated in 2014 and is based in Lund, Sweden.

www.bioextrax.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 85X0.F

View More

Performance Overview: 85X0.F

Trailing total returns as of 4/8/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .

YTD Return

85X0.F
21.85%
OMX Stockholm 30 Index (^OMX)
9.90%

1-Year Return

85X0.F
18.01%
OMX Stockholm 30 Index (^OMX)
11.30%

3-Year Return

85X0.F
92.68%
OMX Stockholm 30 Index (^OMX)
4.94%

5-Year Return

85X0.F
90.02%
OMX Stockholm 30 Index (^OMX)
49.20%

Compare To: 85X0.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 85X0.F

View More

Valuation Measures

Annual
As of 4/7/2025
  • Market Cap

    9.42M

  • Enterprise Value

    7.85M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    141.78

  • Price/Book (mrq)

    3.36

  • Enterprise Value/Revenue

    167.77

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -42.56%

  • Return on Equity (ttm)

    -74.42%

  • Revenue (ttm)

    1.01M

  • Net Income Avi to Common (ttm)

    -17.34M

  • Diluted EPS (ttm)

    -0.0500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    17.27M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -9.63M

Research Analysis: 85X0.F

View More

Company Insights: 85X0.F

Research Reports: 85X0.F

View More

People Also Watch